TS2420628041	sideeffect 3 14	interaction
TS2620628041	drug 23 31	levodopa
TS1120628041	foodSupplement 36 53	enteral nutrition
TS5320628041	sideeffect 67 78;90 113	neuroleptic malignant-like syndrome
TS1720628041	sideeffect 162 173	interaction
TS4920628041	foodSupplement 182 195	enteral feeds
TS1220628041	drug 200 208	levodopa
TS5020628041	sideeffect 220 231;243 275	neuroleptic malignant-like syndrome ( NMLS )
TS4120628041	treatedDisease 305 324	Parkinson's disease
TS120628041	treatedDisease 399 423	type 2 diabetes mellitus
TS5220628041	foodSupplement 482 495	Enteral feeds
TS3520628041	drug 567 574	protein
TS3220628041	drug 633 644	pramipexole
TS1020628041	drug 647 657	entacapone
TS1820628041	drug 682 690	levodopa
TS3820628041	drug 692 701	carbidopa
TS5420628041	foodSupplement 828 841	enteral feeds
TS2920628041	drug 900 907	protein
TS2320628041	sideeffect 1032 1042	high fever
TS3320628041	sideeffect 1064 1076	leukocytosis
TS2720628041	sideeffect 1079 1116	elevated serum creatine kinase ( CK )
TS1320628041	sideeffect 1145 1167	acute renal impairment
TS4720628041	foodSupplement 1174 1191	enteral nutrition
TS320628041	drug 1216 1223	protein
TS3720628041	drug 1279 1292	bromocriptine
TS220628041	drug 1571 1579	levodopa
TS2120628041	foodSupplement 1677 1692	dietary protein
TS1420628041	drug 1725 1733	levodopa
TS720628041	sideeffect 1755 1766	interaction
TS1520628041	drug 1775 1783	levodopa
TS820628041	sideeffect 1852 1863	interaction
R3	decrease_absorption Arg1:TS2120628041 Arg2:TS1420628041
TS3020628041	sideeffect 1918 1943	drug-nutrient interaction
TS2520628041	drug 1961 1969	levodopa
TS1620628041	sideeffect 2158 2169	interaction
TS4020628041	drug 2178 2186	levodopa
TS2220628041	food2 2191 2198	protein
TS3620628041	foodSupplement 2210 2227	enteral nutrition
R5	relation Arg1:TS2220628041 Arg2:TS3620628041
R6	has_sideeffect Arg1:TS2620628041 Arg2:TS5320628041	
R7	increase_side_effect Arg1:TS1120628041 Arg2:TS5320628041	
R8	negative_effect_on_drug Arg1:TS1120628041 Arg2:TS2620628041	
T1	sideeffect 118 136	prolonged ICU stay
R9	relation Arg1:TS1120628041 Arg2:T1	
T2	treatedDisease 327 329	PD
R2	has_sideeffect Arg1:TS1220628041 Arg2:TS5020628041	
R10	treat Arg1:TS1220628041 Arg2:TS4120628041	
R1	negative_effect_on_drug Arg1:TS4920628041 Arg2:TS1220628041	
R11	increase_side_effect Arg1:TS4920628041 Arg2:TS5020628041	
T3	treatedDisease 392 394	PD
T4	dosage 548 558	0.88 g  kg
T5	frequency 560 563	day
T6	treatedDisease 616 618	PD
R12	treat Arg1:TS3220628041 Arg2:T6	
R13	treat Arg1:TS1020628041 Arg2:T6	
T8	modeadm 664 681	immediate-release
R14	treat Arg1:TS1820628041 Arg2:T6	
R15	treat Arg1:TS3820628041 Arg2:T6	
T7	dosage 702 715	100 mg  25 mg
T9	frequency 718 743	1.5 tablets 4 times daily
T10	dosage 882 891	1.8 g  kg
T11	frequency 893 896	day
T12	dosage 1234 1243	1.0 g  kg
T13	frequency 1245 1248	day
T14	dosage 1293 1297	5 mg
T15	frequency 1298 1311	3 times daily
T16	modeadm 1316 1332	nasogastric tube
T17	modeadm 768 784	nasogastric tube
T18	modeadm 518 534	nasogastric tube
T19	treatedDisease 1597 1599	PD
T20	sideeffect 1633 1637	NMLS
R16	has_sideeffect Arg1:TS220628041 Arg2:T20	
R17	treat Arg1:TS220628041 Arg2:T19	
R18	has_sideeffect Arg1:TS2120628041 Arg2:TS720628041	
R4	decrease_absorption Arg1:TS2220628041 Arg2:TS4020628041	
R19	relation Arg1:TS2220628041 Arg2:TS1620628041	
T21	sideeffect 2255 2259	NMLS
R20	has_sideeffect Arg1:TS4020628041 Arg2:T21	
R21	increase_side_effect Arg1:TS2220628041 Arg2:T21	
T22	treatedDisease 2277 2279	PD
R22	treat Arg1:TS4020628041 Arg2:T22	
